On the mechanisms of the antispasmodic action of some hindered phenols in rat aorta rings

被引:31
作者
Fusi, F [1 ]
Marazova, K [1 ]
Pessina, F [1 ]
Gorelli, B [1 ]
Valoti, M [1 ]
Frosini, M [1 ]
Sgaragli, G [1 ]
机构
[1] Univ Siena, Ist Sci Farmacol, I-53100 Siena, Italy
关键词
hindered phenol; BHA (3-t-buty]-4-hydroxyanisole); Ca2+ homeostasis;
D O I
10.1016/S0014-2999(00)00152-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The antispasmodic effects of 3-t-butyl-4-hydroxyanisole (BHA) and some structurally related compounds were investigated in endothelium-intact rat aorta rings. Nordihydroguaieretic acid (NDGA), BHA, 3,5-di-t-butyl-4-hydroxyanisole (DTBHA), 2,6-di-isopropyl phenol (propofol) and 2,2'-dihydroxy-3,3'-di-t-butyl-5,5'-dimethoxydiphenyl (DIBHA) did not cause relaxation when added at the plateau of phenylephrine-evoked contraction, nor did they affect the concentration-relaxation curve for acetylcholine in precontracted rings. In rings depolarised with physiological salt solution (PSS) containing 40 mM K+, NDGA, BHA, DTBHA, 2,5-di-t-butyl-1,4-benzohydroquinone (BHQ), propofol and nifedipine, but not DIBHA, inhibited the contraction induced by cumulative addition of Ca2+ (0.05-10 mM) in a concentration-dependent manner; this inhibition was inversely related to the Ca2+ concentration. In 40 mM K+ PSS, 25 nM nifedipine blocked the 1 mM Ca2+-induced contraction, whereas 50 mu M DTBHA, NDGA, BHA, BHQ and propofol significantly antagonised it by 84.4%, 73.0%, 52.8%, 45.6% and 35.7%, respectively. In the presence of 1 mu M methyl-1,4-dihydro-2,6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl)-pyridine -5-carboxylate (Bay K 8644), the response to Ca2+ did not differ from control values with nifedipine and BHQ, was partially restored with DTBHA and NDGA, and was not affected with BHA and propofol. Nifedipine markedly inhibited (85.2%) the Ba2+-induced contraction and this effect was totally reversed by Bay K 8644. BHA and DTBHA showed antispasmodic activity (45.3% and 43.1%, respectively) which was partly reversed by Bay K 8644. In contrast, Bay K 8644 did not affect the inhibition exerted by BHQ, NDGA and propofol (69.5%, 53.3% and 46.1%, respectively). Nifedipine, BHA, DTBHA, propofol and NDGA inhibited the contractile response to 1 mM Ca2+ of aorta rings depolarised with 40 or 80 mM K+ PSS to a similar extent. Cromakalim inhibited the Ca2+-evoked contraction only in 30 mM K+ PSS and BHQ only in 80 mM K+ PSS. DIBHA had no effect on this model. Cromakalim, but not BHA, stimulated Rb-86(+) efflux from ring preparations. In 80 mM K+ PSS containing 1 mu M nifedipine, only papaverine affected the phenylephrine-induced contraction. Moreover, when the rings were preincubated with 1 mM Ni2+, the response to phenylephrine in the presence of BHQ was significantly reduced. In conclusion; we propose that BHA may non-specifically inhibit Ca2+ influx at the plasmalemma level rather than affect the function of K+ channels, Ca2+ release from intracellular stores or endothelium-dependent relaxation. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:109 / 115
页数:7
相关论文
共 23 条
[11]   CA2+ HOMEOSTASIS IN VASCULAR SMOOTH-MUSCLE [J].
HIMPENS, B ;
MISSIAEN, L ;
CASTEELS, R .
JOURNAL OF VASCULAR RESEARCH, 1995, 32 (04) :207-219
[12]   REACTIONS OF NITRIC-OXIDE WITH PHENOLIC ANTIOXIDANTS AND PHENOXYL RADICALS [J].
JANZEN, EG ;
WILCOX, AL ;
MANOHARAN, V .
JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (14) :3597-3599
[13]  
Karaki H, 1997, PHARMACOL REV, V49, P157
[14]  
KARAKI H, 1987, J PHARMACOL METHOD, V18, P1
[15]  
KORN SJ, 1990, MOL PHARMACOL, V38, P530
[16]  
LINCOLN TM, 1991, BLOOD VESSELS, V28, P129
[17]   COMPARATIVE EFFECTS OF THE POTASSIUM CHANNEL OPENERS CROMAKALIM AND PINACIDIL AND THE CROMAKALIM ANALOG U-89232 ON ISOLATED VASCULAR AND CARDIAC TISSUE [J].
NORMAN, NR ;
TOOMBS, CF ;
KHAN, SA ;
BUCHANAN, LV ;
CIMINI, MG ;
GIBSON, JK ;
MEISHERI, KD ;
SHEBUSKI, RJ .
PHARMACOLOGY, 1994, 49 (02) :86-95
[18]  
PETKOV GV, 1999, PHARMACOL RES S, V39, P54
[20]   OXIDATION OF 2-TERT-BUTYL-4-METHOXYPHENOL (BHA) BY HORSERADISH AND MAMMALIAN PEROXIDASE SYSTEMS [J].
SGARAGLI, G ;
DELLACORTE, L ;
PULITI, R ;
DESARLO, F ;
FRANCALANCI, R ;
GUARNA, A ;
DOLARA, P ;
KOMARYNSKY, M .
BIOCHEMICAL PHARMACOLOGY, 1980, 29 (05) :763-769